DNA — Ginkgo Bioworks Holdings Share News
0.000.00%
Last trade - 00:00- $653.87m
- $351.71m
- $170.16m
Brief: Ginkgo Bioworks Provides Business Updates At J.P. Morgan Healthcare Conference
Brief: Ginkgo Bioworks Completes Program with Biogen to Boost Productivity of Gene Therapy Manufacturing Platform
U.S. STOCKS ON THE MOVE-Coinbase Global, Spirit AeroSystems, Crown Castle
Ginkgo to partner with OneOne Biosciences; shares rise
Brief: OneOne Biosciences Partners with Ginkgo Bioworks to Advance its Platform and Nitrogen Fixation Microbial Product
Brief: U.S. Department of Energy Awards Team Led by Ginkgo Bioworks Funding to Develop Algal Crop Protection Solutions
Brief: Ginkgo Bioworks Receives Grant To Develop Live Cell Delivery Platform Of Antibody Therapeutics For Treating HIV And Malaria
Brief: Arbor Biotechnologies Announces Collaboration With Ginkgo Bioworks
Brief: Agrivalle And Ginkgo Bioworks Enter Multiyear Strategic Partnership To Accelerate Next-Gen AG Biological Products
Brief: Synplogen And Ginkgo Bioworks Announce Plans To Accelerate Global Dna Manufacturing And Gene Therapy Platform Services In Japan
U.S. STOCKS ON THE MOVE-Instacart, Nvidia, Novavax
U.S. STOCKS ON THE MOVE-Emeren Group, Tesla, Parker-Hannifin
Ginkgo falls on rating cut after downbeat cell program forecast
Brief: Ginkgo Bioworks Q3 Net Income USD -302.891 Million
U.S. STOCKS ON THE MOVE-Paramount Global, Bumble, Booking Holdings
US CDC to expand surveillance of traveler samples for respiratory viruses (updated)
U.S. STOCKS ON THE MOVE-Constellation Energy, Bloomin' Brands, Air Lease
U.S. STOCKS ON THE MOVE-Sensei, Celldex, Bluegreen Vacations
Ginkgo rises on expansion of gene testing program